BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24637806)

  • 1. Tyrosine kinases, drugs, and Shigella flexneri dissemination.
    Dragoi AM; Agaisse H
    Gut Microbes; 2014; 5(1):44-7. PubMed ID: 24637806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bruton's tyrosine kinase regulates Shigella flexneri dissemination in HT-29 intestinal cells.
    Dragoi AM; Talman AM; Agaisse H
    Infect Immun; 2013 Feb; 81(2):598-607. PubMed ID: 23230296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WIPF2 promotes Shigella flexneri actin-based motility and cell-to-cell spread.
    Michard C; Yum LK; Agaisse H
    Cell Microbiol; 2019 Dec; 21(12):e13098. PubMed ID: 31414511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and Cellular Mechanisms of Shigella flexneri Dissemination.
    Agaisse H
    Front Cell Infect Microbiol; 2016; 6():29. PubMed ID: 27014639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Shigella flexneri type 3 secretion system is required for tyrosine kinase-dependent protrusion resolution, and vacuole escape during bacterial dissemination.
    Kuehl CJ; Dragoi AM; Agaisse H
    PLoS One; 2014; 9(11):e112738. PubMed ID: 25405985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Intestinal Enteroids as a Model System of
    Koestler BJ; Ward CM; Fisher CR; Rajan A; Maresso AW; Payne SM
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30642906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shigella-mediated oxygen depletion is essential for intestinal mucosa colonization.
    Tinevez JY; Arena ET; Anderson M; Nigro G; Injarabian L; André A; Ferrari M; Campbell-Valois FX; Devin A; Shorte SL; Sansonetti PJ; Marteyn BS
    Nat Microbiol; 2019 Nov; 4(11):2001-2009. PubMed ID: 31383999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The class II phosphatidylinositol 3-phosphate kinase PIK3C2A promotes Shigella flexneri dissemination through formation of vacuole-like protrusions.
    Dragoi AM; Agaisse H
    Infect Immun; 2015 Apr; 83(4):1695-704. PubMed ID: 25667265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two msbB genes encoding maximal acylation of lipid A are required for invasive Shigella flexneri to mediate inflammatory rupture and destruction of the intestinal epithelium.
    D'Hauteville H; Khan S; Maskell DJ; Kussak A; Weintraub A; Mathison J; Ulevitch RJ; Wuscher N; Parsot C; Sansonetti PJ
    J Immunol; 2002 May; 168(10):5240-51. PubMed ID: 11994481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of bacillary dysentery: lessons learnt from infant rabbits.
    Yum LK; Agaisse H
    Gut Microbes; 2020 May; 11(3):597-602. PubMed ID: 31570038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine/threonine kinase STK11 promotes Shigella flexneri dissemination through establishment of cell-cell contacts competent for tyrosine kinase signaling.
    Dragoi AM; Agaisse H
    Infect Immun; 2014 Nov; 82(11):4447-57. PubMed ID: 25114112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shigella flexneri infection is dependent on villin in the mouse intestine and in primary cultures of intestinal epithelial cells.
    Athman R; Fernandez MI; Gounon P; Sansonetti P; Louvard D; Philpott D; Robine S
    Cell Microbiol; 2005 Aug; 7(8):1109-16. PubMed ID: 16008578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The type 3 secretion effector IpgD promotes S. flexneri dissemination.
    Köseoğlu VK; Jones MK; Agaisse H
    PLoS Pathog; 2022 Feb; 18(2):e1010324. PubMed ID: 35130324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for T and NK cells in the innate immune response to Shigella flexneri.
    Le-Barillec K; Magalhaes JG; Corcuff E; Thuizat A; Sansonetti PJ; Phalipon A; Di Santo JP
    J Immunol; 2005 Aug; 175(3):1735-40. PubMed ID: 16034114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calpain activation by Shigella flexneri regulates key steps in the life and death of bacterium's epithelial niche].
    Bergounioux J; Arbibe L
    Med Sci (Paris); 2012 Dec; 28(12):1029-31. PubMed ID: 23290392
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Ferrari ML; Malardé V; Grassart A; Salavessa L; Nigro G; Descorps-Declere S; Rohde JR; Schnupf P; Masson V; Arras G; Loew D; Sansonetti PJ; Sauvonnet N
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13582-13591. PubMed ID: 31209035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
    Newton HJ; Pearson JS; Badea L; Kelly M; Lucas M; Holloway G; Wagstaff KM; Dunstone MA; Sloan J; Whisstock JC; Kaper JB; Robins-Browne RM; Jans DA; Frankel G; Phillips AD; Coulson BS; Hartland EL
    PLoS Pathog; 2010 May; 6(5):e1000898. PubMed ID: 20485572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Oral Inoculation Infant Rabbit Model for
    Kuehl CJ; D'Gama JD; Warr AR; Waldor MK
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964739
    [No Abstract]   [Full Text] [Related]  

  • 19. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.
    Boullier S; Tanguy M; Kadaoui KA; Caubet C; Sansonetti P; Corthésy B; Phalipon A
    J Immunol; 2009 Nov; 183(9):5879-85. PubMed ID: 19828639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of Ipa proteins of Shigella flexneri with alpha5beta1 integrin promotes entry of the bacteria into mammalian cells.
    Watarai M; Funato S; Sasakawa C
    J Exp Med; 1996 Mar; 183(3):991-9. PubMed ID: 8642302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.